Aging Population and Unhealthy Foods Habits to Boost the Sales of Radiopharmaceuticals
A radiopharmaceutical is a radioactive
compound or drug, used for the diagnosis and therapeutic treatment of human
diseases. Gallium Citrate Ga 67, Sodium Fluoride F 18, Technetium Tc 99m
Disofenin, Indium In 111 Pentetreotide, Technetium Tc 99m Arcitumomab are some
examples of the radiopharmaceutical. Radiopharmaceutical has two components;
radionuclide and pharmaceutical. It is a compound manufactured for use as a
medicinal drug, for instance, Prozac. They can be inserted into a vein, taken
by mouth or placed in a body cavity. These are used in various diseases like
blood volume studies, abscess & infection, blood vessel diseases of the
brain, bone diseases and biliary tract blockage etc. Radiopharmaceuticals can
be divided into four categories, are radiopharmaceutical preparation,
radionuclide generator, radiopharmaceutical precursor and kit for
radiopharmaceutical preparation. A radiopharmaceutical preparation is a
medicinal product, suitable for human use which contains a radionuclide, used
for one or more diagnostic or therapeutic applications.
According to study, “GlobalRadiopharmaceutical Market Research Report - Forecast To 2023” some of
the companies that are working in radiopharmaceutical are Bicron, ANSTO,
Capintec, Dupoint, CORPUS, BC technical Inc., Digirad, IZOTOP, GE healthcare,
MEDASYS, Inderlec medical systems, Pharmex, Nuclide navigator lite, SMV nuclear
medicine company, Segami, international, Schiller America, Toshiba medical
system,
Radiopharmaceutical dispensing
recommends dosage level based on patient history, age, weight and surface area
etc. Dispensing also develops policies & procedures to ensure that the
correct drug in the correct dosage & dosage form is received by the correct
patient at the correct time by a correct route of administration. Whereas
distribution of it complies with all applicable regulations concerning
packaging, labeling & transportation of radioactive and other materials.
The advantages of radiopharmaceutical
include diagnosis and treatment of a patient, availability of modes, provide
fast onset of pain relief, single dose effect, cost-effective and no side
effect etc. There are some disadvantages of radiopharmaceutical such as
radiation risk, allergic reaction, prolonged inconvenience &discomfort,
occurring myelosuppression etc.
Radiopharmaceutical market is
segmented in various terms. On the basis of application, the market is
segmented into cardiology, oncology, neurology, and thyroid. On the basis of
modality, a market is segmented into PET, alpha-emitters, beta-emitters, SPECT,
and brachytherapy. On the basis of type, a market is segmented into diagnostic
and therapeutic. On the basis of end-user, the market is segmented into
hospitals & diagnostic centers and research institutes. On the basis of the
type of test, the market is segmented into lung scan, bone scan, gallium scan,
white blood cell scan, renal nuclear scan, parathyroid scans, and hepatobiliary
scans. On the basis of the route of administration, the market is segmented
into intravenous and intravitreal.
The global radiopharmaceutical market was valued at US$5.2 billion in 2017 and
is estimated to reach US$7.4 billion by 2024, expanding at a CAGR of 5.4% from
2017 to 2024. North America is the most attractive regional market in the
global radiopharmaceuticals market. The growth in the region is expected to
continue with the technological improvements in PET scanning devices. The other
factor impacting the global radiopharmaceuticals market is the rising
prevalence of cancer. This has significantly increased the number of nuclear
medicine procedures performed in the region and is on the specific reason that
the market for radiopharmaceuticals is steadily growing in North America. There
have been a rising number of cardiovascular diseases among the people in North
America due to the aging population, unhealthy food habits and rising obesity.
The increasing number of cardiovascular patients is expected to boost the sales
of radiopharmaceuticals, which would eventually create growth in the global
radiopharmaceuticals market.
To know more,
click on the link below:
Contact Us:
Ken
Research
Ankur Gupta,
Head Marketing & Communications
+91-9015378249
Comments
Post a Comment